Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Sally Beauty Stock Jumps 7.8% After Q3 Earnings Beat, Outlook Narrowed
Sally Beauty Stock Jumps 7.8% After Q3 Earnings Beat, Outlook Narrowed

Sally Beauty Holdings, Inc. SBH delivered third-quarter fiscal 2026 results, wherein earnings surpassed the Zacks Consensus Estimate, while revenues fell slightly short. The bottom line improved

NICE vs. ZM: Which Stock Is the Better Value Option?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/ec495607-1e17-40ee-a41d-7726313a9707.png
NICE vs. ZM: Which Stock Is the Better Value Option?

Investors interested in Internet - Software stocks are likely familiar with Nice (NICE) and Zoom Communications (ZM). But which of these two stocks presents investors with the better value

ACCO vs. HLN: Which Stock Is the Better Value Option?
ACCO vs. HLN: Which Stock Is the Better Value Option?

Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Acco Brands (ACCO) and Haleon PLC Sponsored ADR (HLN). But which of these two companies is the

HAYW or HOCPY: Which Is the Better Value Stock Right Now?
HAYW or HOCPY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Electronics - Miscellaneous Products sector have probably already heard of Hayward Holdings, Inc. (HAYW) and Hoya Corp. (HOCPY). But which of these two stocks

Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves

Medifast, Inc. MED reported second-quarter 2026 results, wherein both the top and bottom lines surpassed the Zacks Consensus Estimate. However, both metrics declined year over year.

Medifast's

Palvella Therapeutics Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Palvella Therapeutics Q2 Earnings Call Highlights

Key Points

DDD Q2 Earnings Beat Estimates, Strong Printer Sales Aid Top Line
DDD Q2 Earnings Beat Estimates, Strong Printer Sales Aid Top Line

3D Systems DDD reported a second-quarter 2026 non-GAAP loss of 4 cents per share, narrower than the year-ago loss of 6 cents and beat the Zacks Consensus Estimate by 55.56%.Revenues slipped 0.3%

BTSG Raises 2026 Guidance as Specialty and Home Health Drive Growth
BTSG Raises 2026 Guidance as Specialty and Home Health Drive Growth

BrightSpring Health Services, Inc. BTSG exceeded second-quarter expectations and raised its 2026 outlook as pharmacy and provider operations expanded together. The results strengthened the case that

Motorcycle Accident Lawyer in Texas | The Texas Law DogPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Motorcycle Accident Lawyer in Texas | The Texas Law Dog
A motorcycle accident can result in severe injuries, costly medical expenses, lost wages, and long-term physical and emotional challenges. Working with an experienced Motorcycle Accident Lawyer gives
Is WisdomTree India Earnings ETF (EPI) a Strong ETF Right Now?
Is WisdomTree India Earnings ETF (EPI) a Strong ETF Right Now?

Making its debut on 02/22/2008, smart beta exchange traded fund WisdomTree India Earnings ETF (EPI) provides investors broad exposure to the Asia-Pacific (Emerging) ETFs category of the market.

CRL Q2 Earnings and Revenues Top, '26 View Up, Stock Up in Pre-Market
CRL Q2 Earnings and Revenues Top, '26 View Up, Stock Up in Pre-Market

Charles River Laboratories International, Inc. CRL reported second-quarter 2026 company-defined non-GAAP earnings of $3.02 per share, down 3.2% year over year. The reported earnings topped the Zacks

COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised
COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised

Cencora, Inc. COR reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $4.48, which beat the Zacks Consensus Estimate of $4.37 by 2.5%. The bottom line increased 12% year over

4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns

If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, you can try the growth at a reasonable price or GARP strategy.The strategy helps investors

DD Q2 Earnings Call Points to Faster Second-Half Growth
DD Q2 Earnings Call Points to Faster Second-Half Growth

DuPont de Nemours, Inc. DD used its second-quarter 2026 earnings call to raise its full-year outlook and outline a stronger second half. Adjusted earnings of $1.88 per share topped the Zacks

Disney Q3 Earnings Surpass Estimates, Revenues Increase Y/Y
Disney Q3 Earnings Surpass Estimates, Revenues Increase Y/Y

The Walt Disney Company DIS reported third-quarter fiscal 2026 adjusted earnings of $2.06 per share, up 28% year over year, beating the Zacks consensus estimate of $1.88 by 9.6%.Revenues of $25.25

APEI or LINC: Which Is the Better Value Stock Right Now?
APEI or LINC: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Schools sector have probably already heard of American Public Education (APEI) and Lincoln Educational Services Corporation (LINC). But which of these two

GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook Raised
GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook Raised

Gilead Sciences, Inc. GILD reported a second-quarter 2026 adjusted loss of $6.75 per share, narrower than the Zacks Consensus Estimate of a loss of $7.07. In the year-ago quarter, GILD posted

Innoviz Technologies Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Car rental company, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-Ew7cRec38UnlyYzs41FVEri5.png?st=2023-12-29T14%3A03%3A41Z&se=2023-12-29T16%3A03%3A41Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-12-29T15%3A03%3A25Z&ske=2023-12-30T15%3A03%3A25Z&sks=b&skv=2021-08-06&sig=vZPI3wL5I%2BC5Zknik6hYtwmYdTdsE1ct/DM1evRA8EI%3D
Innoviz Technologies Q2 Earnings Call Highlights

Key Points

Earnings Estimates Rising for FormFactor (FORM): Will It Gain?
Earnings Estimates Rising for FormFactor (FORM): Will It Gain?

FormFactor (FORM) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since

Victoria's Secret Crushed the Quarter, But These Wall Street Analysts Think the Excitement May Be Overdone

Victoria's Secret Crushed the Quarter, But These Wall Street Analysts Think the Excitement May Be Overdone